Allarity Therapeutics, Inc. (ALLR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 25K | 320K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | -26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | -104% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 51K | 320K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 204% | 100% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.74M | 3.24M | 2.52M | 4.13M | 3.04M | 7.32M | 12.31M | 3.37M | 4.24M | 4.88M | 4.43M | 4.16M |
| OpEx % of Revenue | 10956% | 1011.88% | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.42M | 1.56M | 1.31M | 1.81M | 1.63M | 5.47M | 1.59M | 2.31M | 2.07M | 2.26M | 2.48M | 3.05M |
| SG&A % of Revenue | 5664% | 488.75% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.3M | 1.67M | 1.2M | 2.32M | 1.4M | 1.85M | 1.02M | 1.06M | 2.17M | 2.62M | 1.95M | 1.1M |
| R&D % of Revenue | 5188% | 523.13% | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 26K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.69M | -2.92M | -2.52M | -4.13M | -3.04M | -7.32M | -12.31M | -3.37M | -4.24M | -4.88M | -4.43M | -4.16M |
| Operating Margin % | -10752% | -911.88% | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 11.46% | 60.12% | 79.55% | -22.6% | 28.4% | -49.97% | -178.2% | 18.89% | -15.59% | 27.72% | 2.98% | 14.17% |
| EBITDA | -2.71M | -2.91M | -2.56M | -4.12M | -3.02M | -7.32M | -12.31M | -3.37M | -4.24M | -4.87M | -4.42M | -4.15M |
| EBITDA Margin % | -10856% | -909.38% | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 10.28% | 60.22% | 79.18% | -22.28% | 28.62% | -50.23% | -178.65% | 18.74% | -15.86% | 27.83% | 2.94% | 13.93% |
| D&A (Non-Cash Add-back) | -26K | 8K | -44K | 12K | 11K | 1K | 5K | 1K | 2K | 9K | 9K | 9K |
| EBIT | -2.69M | -3.31M | -2.75M | -2.31M | -2.67M | -7.38M | -11.92M | -1.2M | -3.75M | -1.41M | -4.41M | -2.24M |
| Net Interest Income | -66K | 96K | 130K | 225K | 165K | 144K | 211K | -373K | -102K | -227K | -22K | -139K |
| Interest Income | 163K | 155K | 187K | 237K | 222K | 219K | 261K | 53K | 0 | 3K | 12K | 3K |
| Interest Expense | 229K | 59K | 57K | 12K | 57K | 75K | 50K | 426K | 102K | 230K | 34K | 142K |
| Other Income/Expense | -62K | -455K | -288K | 1.81M | 304K | -136K | 346K | 1.74M | 393K | 3.24M | -21K | 1.78M |
| Pretax Income | -2.75M | -3.37M | -2.81M | -2.32M | -2.73M | -7.45M | -11.97M | -1.63M | -3.85M | -1.64M | -4.45M | -2.38M |
| Pretax Margin % | -11000% | -1054.06% | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | -377K | 0 | -4K | 83K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 3.15% | 0% | 0.1% | -5.06% | 0% | 0% |
| Net Income | -2.75M | -3.37M | -2.81M | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M | -1.72M | -4.45M | -2.38M |
| Net Margin % | -11000% | -1054.06% | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.66% | 54.74% | 75.79% | -42.42% | 28.91% | -332.81% | -160.63% | 31.55% | -14.65% | 39.32% | 11.71% | 53.36% |
| Net Income (Continuing) | -2.75M | -3.37M | -2.81M | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M | -1.72M | -4.45M | -2.38M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.17 | -0.21 | -0.19 | -0.15 | -0.25 | -1.02 | -7.71 | -3.40 | -20905.00 | -175.51 | -1346.09 | -15766.00 |
| EPS Growth % | 32% | 79.41% | 97.54% | 95.59% | 100% | 99.42% | 99.43% | 99.98% | 80.32% | 99.91% | 99.76% | 97.39% |
| EPS (Basic) | -0.17 | -0.21 | -0.19 | -0.15 | -0.25 | -1.02 | -7.71 | -3.40 | -20905.00 | -175.51 | -1346.09 | -15766.00 |
| Diluted Shares Outstanding | 15.97M | 14.38M | 14.74M | 15.54M | 11.15M | 7.3M | 1.58M | 499.3K | 194.73K | 9.81M | 4.12M | 620.69K |
| Basic Shares Outstanding | 15.97M | 14.38M | 14.74M | 15.54M | 11.15M | 7.3M | 1.58M | 499.3K | 194.73K | 9.81M | 4.12M | 620.69K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |